Market Summary and Growth Forecast
The global Hospital Exercise Equipment Market is estimated at $2,050 million in 2026 and is expected to reach $3,740 million by 2035, growing at a CAGR of 6.9%.
The market covers equipment purchased by hospitals and hospital-owned rehabilitation facilities for supervised therapeutic exercise, physical conditioning, functional recovery, and mobility training. It includes medical treadmills, exercise cycles, upper- and lower-body ergometers, resistance systems, gait trainers, balance platforms, robotic rehabilitation systems, and therapeutic exercise stations.
Request free sample at https://datavagyanik.com/reports/global-hospital-exercise-equipment-market/
The scope excludes consumer home-gym products, wheelchairs, prosthetics, diagnostic imaging systems, rehabilitation services, and general physiotherapy consumables. This keeps the Hospital Exercise Equipment Market focused on capital equipment used to restore strength, endurance, balance, coordination, and movement.
Market Forecast
| Indicator | Estimate |
| Global market size in 2026 | $2,050 million |
| Interim market size in 2030 | $2,680 million |
| Projected market size in 2035 | $3,740 million |
| CAGR, 2026–2035 | 6.9% |
These figures are analyst-built estimates rather than values taken from a published market research report. The model triangulates revenue benchmarks from commercial exercise-equipment suppliers and specialist rehabilitation-technology companies. It then applies hospital-use, product-scope, geographic, replacement-cycle, and average-selling-price filters. For context, Technogym reported total revenue of €1,019 million in 2025, while specialized rehabilitation businesses such as DIH and Ekso Bionics operate on a much smaller revenue base. This difference reflects a fragmented industry that combines high-volume exercise equipment with low-volume, high-value robotic systems.
Request free sample at https://datavagyanik.com/reports/global-hospital-exercise-equipment-market/
Why the Market Matters
Hospital rehabilitation is no longer treated only as a post-surgery support service. It is becoming part of the clinical pathway for stroke, joint replacement, spinal injury, cardiac disease, pulmonary illness, trauma, cancer recovery, and age-related loss of mobility.
The underlying patient pool is large. The World Health Organization estimates that 2.4 billion people live with conditions that may benefit from rehabilitation. Demand will continue to rise as populations age and more patients live longer with chronic diseases and functional limitations.
Hospitals also face practical pressure. Therapists need to manage more patients without reducing treatment quality. Equipment that supports repeatable exercise, adjustable resistance, patient unloading, objective measurement, and automated session records can improve treatment consistency. It can also reduce physical strain on clinical staff.
Main Growth Forces
Technology modernization: Hospitals are replacing isolated mechanical devices with equipment that measures speed, power, range of motion, gait symmetry, heart rate, repetition count, and exercise quality. Connected systems also help clinicians compare performance across sessions.
Expansion of neurological and geriatric rehabilitation: Stroke, spinal injury, Parkinson’s disease, frailty, and fall-related conditions require repeated movement training. These applications support demand for gait systems, body-weight-support equipment, balance platforms, and motor-assisted devices.
Growth in orthopedic procedures: Joint replacement and musculoskeletal surgery create recurring demand for controlled strengthening and cardiovascular conditioning. Hospitals increasingly want equipment that can serve patients at different mobility levels.
Regulatory separation between fitness and medical equipment: A standard exercise machine may be treated as commercial fitness equipment. Once the manufacturer makes a medical or restorative claim, the device may fall under medical-device rules. The US FDA maintains classifications for non-measuring, measuring, interactive, and powered rehabilitation exercise equipment. Some interactive rehabilitation systems are classified as prescription Class II devices.
Request free sample at https://datavagyanik.com/reports/global-hospital-exercise-equipment-market/
In Europe, products marketed with a medical intended purpose must meet the applicable requirements of the Medical Devices Regulation. The regulation has applied to new medical devices since May 26, 2021. This raises documentation, clinical evaluation, quality, and post-market obligations for suppliers making therapeutic claims.
Higher-value equipment mix: Basic exercise stations will continue to generate steady replacement demand. Faster revenue expansion will come from sensorized ergometers, robotic gait systems, interactive balance platforms, and software-enabled resistance equipment.
Key Consumers and Clients
The principal buyers are:
- General and multispecialty hospitals
- Inpatient rehabilitation hospitals
- Orthopedic and musculoskeletal hospitals
- Neurological and spinal-injury centres
- Cardiac and pulmonary rehabilitation departments
- Academic medical centres and teaching hospitals
- Government, military, and veterans’ hospitals
- Hospital-owned outpatient rehabilitation facilities
- Integrated health systems and centralized procurement groups
Analyst view: The strongest commercial opportunity will sit between basic fitness equipment and expensive rehabilitation robotics. Hospitals want systems that provide measurable clinical value without requiring major changes to staffing, floor space, or treatment workflows.
Market Segmentation and Forecast Scope
For forecasting, the Hospital Exercise Equipment Market is segmented by product type, clinical application, end user, and region. The structure separates equipment form from clinical use. That matters because the same medical cycle or resistance machine may be used in orthopedic, cardiac, neurological, or geriatric rehabilitation.
Segmentation Framework
| Segmentation Dimension | Sub-segments Covered | Forecast Logic |
| By Product Type | Cardiovascular and ergometry systems; strength and resistance systems; gait, balance and mobility systems; robotic and motor-assisted rehabilitation systems; therapeutic exercise accessories and modular stations | Measures revenue by the equipment’s principal physical and therapeutic function |
| By Application | Musculoskeletal and orthopedic rehabilitation; neurological rehabilitation; cardiac and pulmonary rehabilitation; geriatric and deconditioning care; sports injury and other recovery applications | Measures demand according to the condition or recovery pathway being treated |
| By End User | General and multispecialty hospitals; inpatient rehabilitation hospitals; specialty hospitals; academic and teaching hospitals; hospital-owned outpatient rehabilitation centres | Separates purchasing behaviour by facility type, clinical intensity, and capital budget |
| By Region | North America; Europe; Asia Pacific; Latin America, Middle East and Africa | Captures differences in rehabilitation infrastructure, hospital investment, regulation, reimbursement, and equipment localization |
By Product Type
Cardiovascular and Ergometry Systems
This segment includes medical treadmills, recumbent cycles, upright cycles, arm ergometers, combined upper- and lower-body trainers, steppers, and related cardiovascular assessment equipment.
It is estimated to account for 30.7% of global revenue in 2026. The segment has a broad installed base because the equipment is used across cardiac, pulmonary, orthopedic, geriatric, and general reconditioning programmes.
Growth will be steady rather than disruptive. Most demand will come from equipment replacement, expansion of cardiac rehabilitation capacity, accessible designs, and integration of clinical performance data.
Strength and Resistance Systems
This category includes pneumatic, electronic, hydraulic, cable-based, selectorized, and isokinetic exercise systems. Hospital models differ from conventional gym machines through lower starting resistance, wheelchair accessibility, smaller adjustment increments, enhanced support, and clinician-controlled settings.
Demand will be supported by orthopedic recovery, frailty management, fall prevention, and post-acute strengthening. Pneumatic and electronically controlled resistance systems will gain share because they allow smoother loading and more precise progression.
Gait, Balance and Mobility Systems
This segment covers body-weight-support systems, parallel bars, balance platforms, instrumented walkways, overground gait trainers, suspension systems, and mobility-training stations.
It is strategically important because falls, stroke, neurological injury, and age-related mobility loss require repeated balance and walking practice. Hospitals also value equipment that reduces manual lifting and allows therapists to work safely with high-dependency patients.
Robotic and Motor-Assisted Rehabilitation Systems
This includes robotic gait trainers, powered exoskeletons, motor-assisted cycling systems, upper- and lower-limb robotic trainers, and interactive movement platforms.
It will be the fastest-growing product category with a projected CAGR of around 10.6% from 2026 to 2035. Its revenue contribution will remain smaller than conventional exercise equipment because purchasing costs are high and implementation requires staff training, clinical protocols, maintenance support, and sufficient patient throughput.
Therapeutic Exercise Accessories and Modular Stations
This category covers pedal exercisers, pulley stations, therapy steps, wall-mounted exercise units, mats, balls, bands, weighted systems, and other durable therapeutic accessories supplied as part of hospital exercise areas.
Revenue growth will be moderate. Yet the segment remains important because it supports flexible room layouts and lower-cost treatment programmes.
By Application
Musculoskeletal and Orthopedic Rehabilitation
This is the largest clinical application. It includes recovery following joint replacement, fracture, ligament injury, spinal procedures, trauma, and other musculoskeletal conditions.
The category supports demand for cycles, treadmills, resistance machines, balance systems, and progressive functional-training stations. Procurement tends to favour versatile equipment that can treat a wide range of patients.
Neurological Rehabilitation
This will be the fastest-growing application, advancing at an estimated CAGR of 8.4%. Stroke, spinal-cord injury, brain injury, Parkinson’s disease, multiple sclerosis, and other neurological conditions require high-repetition and task-specific training.
The segment is also the main adoption area for robotics, body-weight support, virtual feedback, motion sensors, and adaptive exercise software.
Cardiac and Pulmonary Rehabilitation
Demand centres on controlled cardiovascular training with continuous or periodic monitoring. Medical cycles, treadmills, arm ergometers, and recumbent systems are widely used.
Growth will depend on hospital referral programmes, chronic respiratory disease management, post-cardiac-event recovery, and the availability of reimbursed rehabilitation pathways.
Geriatric and Deconditioning Care
Hospitals use exercise equipment to rebuild strength, balance, and endurance following prolonged illness, surgery, intensive-care stays, or age-related decline.
Low-entry resistance, stable seating, simple controls, and fall-protection features are especially important here.
Sports Injury and Other Recovery Applications
This application includes hospital sports-medicine departments, trauma recovery, cancer rehabilitation, occupational rehabilitation, and general physical reconditioning.
The category often uses higher-performance resistance and cardiovascular systems but still requires clinical measurement, controlled progression, and accessibility.
By End User
General and Multispecialty Hospitals purchase broad equipment packages. Their priority is versatility.
Inpatient Rehabilitation Hospitals invest more heavily in gait, balance, robotic, and intensive repetition systems. Their equipment utilization rates are usually higher.
Specialty Hospitals select equipment around focused clinical programmes such as orthopedics, neurology, cardiac care, or spinal rehabilitation.
Academic and Teaching Hospitals are early adopters of measurement systems, robotics, virtual environments, and research-grade movement technology.
Hospital-Owned Outpatient Rehabilitation Centres favour compact equipment, easier workflows, digital records, and systems that can support higher daily patient volumes.
By Region
North America is estimated to represent 38.6% of global revenue in 2026. The region benefits from established inpatient rehabilitation networks, advanced hospital procurement, specialist clinical programmes, and early adoption of high-value rehabilitation technology.
Europe has strong rehabilitation infrastructure and a mature supplier base. Demand is influenced by public healthcare budgets, medical-device compliance, ageing populations, and replacement of older hospital equipment.
Asia Pacific will be the fastest-growing regional market, with an estimated CAGR of approximately 8.1%. Expansion will come from new hospitals, rehabilitation centres, ageing populations, private healthcare investment, and improving access to advanced equipment in China, India, Japan, South Korea, Southeast Asia, and Australia.
Latin America, Middle East and Africa will show uneven adoption. Private hospitals and major urban rehabilitation facilities will lead purchasing. Distributor coverage, maintenance availability, import costs, and government healthcare spending will determine the pace of expansion.
Analyst view: The strategic centre of the Hospital Exercise Equipment Market is shifting from stand-alone machines toward connected equipment groups. A hospital may still buy a cycle or resistance station, but future procurement decisions will increasingly consider data capture, patient accessibility, clinical workflow, and compatibility with the wider rehabilitation department.
Market Trends and Innovation Landscape
Innovation in the Hospital Exercise Equipment Market is moving in one clear direction: from mechanical exercise delivery toward measured, adaptive, and digitally documented rehabilitation.
Hospitals are not simply looking for more equipment. They want better information from each session. How much work did the patient perform? Was movement symmetrical? Did strength improve? Was the prescribed range of motion maintained? Can the therapist review progress without manually entering every result?
Major Technology and Innovation Trends
| Trend | Current Development | Expected Commercial Impact |
| Sensor-Based Exercise Measurement | Force, speed, balance, gait, repetition, range-of-motion, and workload sensors are being embedded into equipment | Supports objective progress tracking and strengthens the value case for premium systems |
| Adaptive Resistance and Assistance | Equipment automatically adjusts resistance or motor assistance according to patient ability | Allows weaker and higher-dependency patients to participate earlier in rehabilitation |
| Robotic Gait and Limb Training | Repetitive walking and limb exercises are supported by robotics, exoskeletons, and body-weight-support systems | Raises treatment intensity and reduces some manual handling demands |
| Interactive and Virtual Rehabilitation | Screens, cameras, gamified tasks, augmented environments, and visual feedback are added to exercise programmes | Improves engagement and provides measurable task-based training |
| AI-Assisted Movement Analysis | Computer vision and machine learning assess posture, exercise completion, and movement quality | May automate parts of assessment and documentation but will remain clinician-supervised |
| Connected Equipment Management | Hospitals can manage user profiles, equipment settings, service requirements, and performance data across multiple devices | Creates recurring software and service revenue for suppliers |
| Accessible and Space-Efficient Design | Lower step heights, wheelchair access, rotating seats, compact frames, and simple interfaces are becoming standard procurement factors | Broadens the usable patient population and improves room utilization |
R&D Evolution
Earlier hospital exercise equipment focused on mechanical safety and basic workload control. R&D now combines biomechanics, embedded electronics, software, human-machine interaction, and clinical data.
For conventional equipment, development priorities include smaller resistance increments, safer entry and exit, stable seating, simplified adjustment, energy efficiency, and easier cleaning.
For advanced systems, R&D focuses on patient-specific assistance, sensor fusion, real-time feedback, virtual environments, and automated treatment records. DIH, for example, develops robotic and interactive systems for gait, balance, arm, and hand rehabilitation. Ekso Bionics combines wearable robotics with software-supported gait training.
The FDA’s definition of an interactive rehabilitation exercise device already reflects this transition. Such systems may use sensors, cameras, and screens to track movement and provide feedback during prescribed exercises.
Expert view: The next generation of equipment won’t replace the therapist. It will give the therapist a more consistent way to prescribe, measure, and adjust exercise.
AI and Computer-Vision Integration
AI is relevant to this market, but its near-term role should not be overstated. The practical applications are motion detection, repetition counting, exercise scoring, adaptive difficulty, posture analysis, and identification of unusual movement patterns.
The technology is most useful when it reduces routine observation and documentation work. It is less likely to replace clinical judgement, especially for complex neurological and post-surgical patients.
In October 2024, Medbridge acquired Rehab Boost, a motion-capture and movement-based AI company. The technology was repositioned as an in-house motion-analysis capability for rehabilitation and musculoskeletal care. This transaction shows how digital rehabilitation companies are building computer-vision capabilities rather than relying only on exercise-content libraries.
Expert view: AI will first appear as a measurement layer. The winning systems will be those that turn movement data into a simple clinical action rather than giving therapists another dashboard to manage.
Robotics Moving Into Standard Clinical Programmes
Robotic systems were once purchased mainly by research hospitals and flagship rehabilitation centres. Adoption is gradually extending into broader inpatient rehabilitation networks.
In June 2024, Ekso Bionics entered a research partnership with Shepherd Center to expand the use of its exoskeleton systems across rehabilitation and community settings. The programme was designed to develop implementation, research, and training practices around the technology.
In January 2025, DIH partnered with Nobis Rehabilitation Partners. Under the programme, Nobis planned to integrate an overground gait and balance device into newly established rehabilitation hospitals. This is commercially important because it represents standardized technology deployment across a hospital network rather than a single flagship installation.
The limitation is economics. Robotics requires capital approval, staff training, servicing, and enough eligible patients to justify utilization. So adoption will remain concentrated in neurorehabilitation, spinal injury, stroke, and high-intensity inpatient programmes.
Connected Equipment and Recurring Revenue
Suppliers are gradually moving beyond one-time equipment sales. Software licenses, training, clinical integration, preventive maintenance, remote support, subscriptions, and extended service contracts are becoming part of the commercial model.
Ekso Bionics, for example, reports revenue from device sales, subscriptions, support, and maintenance contracts. Its disclosed contracts may extend for 12 to 48 months, while device subscriptions are commonly recognized across approximately 24 months.
For hospitals, this changes procurement analysis. The purchase price is only one part of the cost. Buyers must also evaluate software fees, equipment uptime, staff certification, spare-parts availability, cybersecurity, data ownership, and long-term vendor support.
Partnerships and Distribution Expansion
Partnerships are becoming a central route to market because rehabilitation equipment requires local installation, clinical training, and technical support.
In December 2024, DIH designated Sheltering Arms Institute, developed with VCU Health, as a rehabilitation-technology centre of excellence. The hospital uses a portfolio of gait, balance, early-mobilization, and upper-limb systems.
In February 2025, DIH expanded its distribution partnership with Zahrawi Group to include Saudi Arabia. The arrangement extended the companies’ coverage across the UAE, Qatar, Bahrain, and Saudi Arabia. This reflects growing demand for specialized rehabilitation infrastructure in Gulf healthcare systems.
Future Innovation Impact
By 2035, equipment differentiation will depend less on basic mechanical specifications. Hospitals will compare systems through clinical usability, patient accessibility, data quality, service support, and the ability to fit established care pathways.
Robotics will record the fastest revenue growth. Still, connected cardiovascular, resistance, balance, and mobility systems will generate the larger addressable opportunity. They serve more patients and require less operational change.
Expert view: By 2035, the Hospital Exercise Equipment Market will not be divided simply between conventional and robotic products. It will be divided between equipment that produces usable clinical data and equipment that does not.
Competitive Intelligence and Benchmarking
The competitive structure of the Hospital Exercise Equipment Market is fragmented. No single company controls every equipment category. Broad fitness-equipment manufacturers compete in cardiovascular and strength systems, while specialist suppliers lead robotics, gait training, balance assessment, and functional rehabilitation.
Technogym
Technogym has one of the broadest portfolios among the companies assessed. Its offering spans connected treadmills, cycles, upper-body ergometers, resistance equipment, functional training systems, and digital exercise-management tools for medical and rehabilitation facilities.
Its main advantage is scale. Hospitals can source multiple equipment categories through one supplier and connect them through a common digital environment. This makes Technogym competitive in large rehabilitation departments, orthopedic hospitals, sports-medicine centres, and hospital wellness programmes. Its position is less specialized in high-dependency robotic rehabilitation than that of dedicated neurorehabilitation companies.
DIH / Hocoma
DIH, through its Hocoma rehabilitation technology portfolio, concentrates on robotic and sensor-based systems for gait, balance, upper-limb movement, early mobilization, and interactive therapy.
The company holds a strong position in premium neurological rehabilitation. Its systems are commonly considered by specialist hospitals treating stroke, spinal-cord injury, traumatic brain injury, and severe mobility impairment. The portfolio also includes clinical software and visual-feedback capabilities.
Its competitive strength comes from the breadth of its robotic rehabilitation ecosystem. However, procurement requires larger capital budgets, staff training, installation support, and sufficient patient volume. This limits adoption in smaller hospitals.
Ekso Bionics
Ekso Bionics focuses on wearable robotic exoskeletons used for gait rehabilitation and mobility support. Its hospital systems target patients recovering from stroke, spinal-cord injury, multiple sclerosis, brain injury, and other neurological conditions.
The company occupies a narrower but technically differentiated position. Instead of supplying a complete rehabilitation gym, it provides high-value robotic systems that allow therapists to initiate supported walking and collect patient and device performance data.
Its installed network includes hundreds of rehabilitation centres globally. Growth depends on broader clinical acceptance, reimbursement, therapist certification, and hospitals demonstrating sufficient utilization to justify the investment.
HUR
HUR supplies pneumatic resistance equipment, strength-measurement systems, balance platforms, and digitally managed exercise solutions. Its equipment is designed for rehabilitation, active ageing, inclusive exercise, and senior care.
The company is well positioned between basic mechanical equipment and expensive rehabilitation robotics. Pneumatic resistance allows patients to begin with low loads and progress in small increments. This is valuable in geriatric, orthopedic, cardiac, and post-operative rehabilitation.
HUR is particularly competitive in hospitals seeking a complete strength-training circuit that is accessible, compact, and easier to operate than robotic systems. Its market presence is supported by distributors and clinical references across Europe, Asia, and North America.
BTE Technologies
BTE Technologies specializes in functional evaluation, objective strength testing, balance training, neuromuscular re-education, hand therapy, and simulation of work or daily-living activities.
Its competitive position is strongest in data-driven physical and occupational therapy. Hospitals can use the same systems for assessment, exercise prescription, functional training, progress measurement, and payer documentation.
The portfolio is especially relevant to orthopedic rehabilitation, occupational medicine, upper-extremity recovery, neurological rehabilitation, and return-to-work programmes. Its main limitation is a narrower cardiovascular and gait-robotics offering compared with broader equipment suppliers.
P&S Mechanics
P&S Mechanics is a South Korean rehabilitation-robotics company focused on robot-assisted gait-training systems for adult and paediatric patients.
Its equipment supports neurological and musculoskeletal rehabilitation while measuring gait-related variables such as joint movement, force, stiffness, and walking patterns. The company is strategically relevant because it represents the growing Asian supplier base competing with established European and US rehabilitation-technology firms.
Its opportunity lies in Asian hospitals seeking locally manufactured robotic equipment, regional technical support, and potentially lower procurement costs than imported premium systems.
Competitive Benchmark
| Company | Primary Competitive Area | Market Position | Main Limitation |
| Technogym | Connected cardiovascular and resistance equipment | Broad global supplier | Less focused on complex robotic neurorehabilitation |
| DIH / Hocoma | Gait, balance and upper-limb robotics | Premium rehabilitation-technology specialist | High capital and implementation requirements |
| Ekso Bionics | Wearable robotic gait systems | Differentiated exoskeleton specialist | Narrower equipment portfolio |
| HUR | Pneumatic strength and active-ageing systems | Strong mid-range clinical solution provider | Limited presence in advanced gait robotics |
| BTE Technologies | Functional testing and measurable rehabilitation | Strong in clinical data and task simulation | Limited conventional cardio portfolio |
| P&S Mechanics | Robotic gait rehabilitation | Emerging Asian technology supplier | Smaller international service network |
Expert view: Competitive advantage will increasingly depend on clinical integration rather than equipment mechanics alone. Hospitals will favour suppliers that combine hardware, measurable outcomes, staff training, servicing, and usable patient data.
Regional Landscape and Adoption Outlook
Regional demand in the Hospital Exercise Equipment Market varies according to hospital capacity, rehabilitation reimbursement, ageing demographics, medical-device regulation, and access to trained therapists.
United States
The United States remains the largest national market. It has an established network of inpatient rehabilitation facilities, hospital-based outpatient centres, academic hospitals, veterans’ facilities, and specialist neurological rehabilitation institutions.
Purchasing is supported by relatively high capital budgets and structured reimbursement for rehabilitation services. For FY 2026, the Centers for Medicare & Medicaid Services finalized a 2.6% increase in inpatient rehabilitation facility payment rates. This supports facility revenue, although it does not guarantee separate reimbursement for equipment purchases.
US hospitals lead the adoption of robotic gait systems, exoskeletons, instrumented balance equipment, and connected functional-assessment platforms. Still, procurement committees increasingly demand utilization forecasts, clinical evidence, cybersecurity controls, service agreements, and measurable productivity benefits.
The strongest demand will remain in states with large hospital systems, rehabilitation networks, older populations, and extensive stroke and orthopedic care infrastructure.
Europe
Europe is a mature but regulation-intensive market. Germany, France, the United Kingdom, Italy, Switzerland, the Netherlands, and the Nordic countries represent the strongest commercial opportunities.
The region has well-developed physiotherapy and rehabilitation infrastructure. It is also home to several established equipment manufacturers, including Technogym, Hocoma, and HUR.
Products marketed with a medical purpose must comply with the applicable requirements of the European Medical Devices Regulation. Software and AI-enabled medical devices can also fall under overlapping medical-device and artificial-intelligence requirements. This raises the evidence and compliance threshold for advanced connected equipment.
Publicly funded hospitals often use formal tender processes. So adoption can be slower than in private US facilities. Once approved, however, suppliers may secure larger multi-hospital contracts.
Western and Northern Europe will favour replacement and digital upgrades. Central and Eastern Europe offer stronger volume growth as hospitals modernize rehabilitation departments.
China
China is expected to be one of the fastest-growing national markets. Demand is being shaped by population ageing, hospital expansion, local robotics manufacturing, and government support for rehabilitation and elderly-care technology.
Government guidelines released in January 2026 called for greater use of technologies such as exoskeleton robots, muscle-support systems, and brain-computer interfaces to assist elderly people with declining physical function. Chinese policy has also encouraged rehabilitation robots and other intelligent products within the broader silver economy.
Tier-one cities such as Beijing, Shanghai, Guangzhou, Shenzhen, and Hangzhou will lead premium-system adoption. Provincial hospitals and elderly-care institutions will create demand for lower-cost cycles, resistance systems, balance equipment, and locally manufactured rehabilitation robots.
Domestic suppliers will gain share because they can compete on price, customization, local tenders, and technical support. International companies will remain influential in premium academic and neurological hospitals.
India
India remains an emerging and highly price-sensitive market. Demand is concentrated in private multispecialty hospitals, orthopedic chains, neurological centres, sports-medicine facilities, teaching hospitals, and major government institutions.
Government hospital standards recognize exercise therapy as part of physiotherapy services. Public programmes for elderly healthcare also include rehabilitative services at different levels of the health system.
Basic treadmills, cycles, pulley systems, resistance stations, and therapy accessories are often sourced locally. Imported robotic and instrumented systems are concentrated in premium hospitals located in Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Pune, and other large cities.
Growth will be supported by rising joint-replacement volumes, stroke cases, private hospital investment, medical tourism, and wider recognition of structured rehabilitation. However, low rehabilitation reimbursement and limited capital budgets will restrict advanced-equipment adoption outside major urban centres.
Japan
Japan has one of the most established rehabilitation and elderly-care ecosystems. Rehabilitation is integrated into hospitals, long-term-care facilities, outpatient centres, and community-based services.
Japan’s long-term-care framework includes rehabilitation and functional training intended to help older people maintain or recover independence. The country also has a defined regulatory and insurance-coverage process for new medical devices.
Market growth will be steady rather than rapid. The installed base is already mature. Demand will centre on replacement equipment, compact designs, fall-prevention systems, strength measurement, robotic assistance, and equipment that reduces staff workload.
Domestic engineering capabilities are strong. Yet suppliers must demonstrate clinical value and fit within tightly controlled reimbursement and hospital-budget structures.
South Korea
South Korea combines advanced hospital infrastructure with a strong robotics, electronics, and medical-device manufacturing base.
Local suppliers have developed adult and paediatric robotic gait systems with integrated clinical measurement. This gives South Korea a stronger domestic technology base than many similarly sized healthcare markets.
Adoption is concentrated in major university hospitals, rehabilitation hospitals, and specialist neurological facilities. Seoul and other large metropolitan areas lead purchasing.
The market will benefit from ageing-related care demand and community-integrated healthcare initiatives. However, national insurance controls and hospital budget discipline require suppliers to demonstrate clear clinical and operational value.
Middle East
The Middle East is relevant mainly through Saudi Arabia, the United Arab Emirates, Qatar, and selected hospital projects in Kuwait and Bahrain.
Saudi Arabia offers the largest long-term opportunity. Its Health Sector Transformation Program aims to create a more integrated, accessible, and value-based healthcare system. Hospital expansion and private-sector participation support demand for imported rehabilitation technology.
In February 2025, DIH expanded its regional distribution partnership with Zahrawi Group to include Saudi Arabia alongside the UAE, Qatar, and Bahrain. This shows that advanced rehabilitation suppliers are strengthening local installation, sales, and service capacity.
The UAE will remain a premium early-adoption market. Saudi Arabia will deliver greater volume. Success will depend heavily on distributors, government tenders, clinical training, spare-parts availability, and long-term maintenance contracts.
Regional Comparison
| Region | Infrastructure Level | Main Funding Model | Adoption Outlook |
| United States | Very high | Insurance reimbursement and hospital capital budgets | Largest current market |
| Western Europe | High | Public healthcare budgets and tenders | Mature replacement and digital-upgrade demand |
| China | Rapidly expanding | Government, public hospitals and private investment | Among the fastest-growing markets |
| India | Uneven | Private hospital capital and selective public procurement | High potential but price constrained |
| Japan | Very high | Public insurance and long-term-care funding | Mature, replacement-led market |
| South Korea | High | National insurance, hospital budgets and technology programmes | Strong robotics opportunity |
| Middle East | High in leading Gulf markets | Government investment, private hospitals and public-private projects | Strong premium-equipment growth |
Expert view: Asia will contribute the largest volume of new installations through 2035. North America and Western Europe will continue to generate higher revenue per installation because they purchase more software, measurement systems, robotics, training, and service support.
Recent Developments, Opportunities and Restraints
Recent activity in the Hospital Exercise Equipment Market shows a shift toward network-level procurement, artificial-intelligence-enabled movement analysis, and stronger distribution coverage in emerging healthcare markets.
Recent Developments
July 2024 – US inpatient rehabilitation funding increased
The Centers for Medicare & Medicaid Services finalized a 3.0% increase in inpatient rehabilitation facility payment rates for FY 2025. The technical rate changes were estimated to increase payments by approximately $280 million. This supported the financial environment for rehabilitation providers, although individual equipment budgets remained facility dependent.
October 2024 – Medbridge acquired an AI motion-capture company
Medbridge acquired Rehab Boost and relaunched its capabilities as an internal motion-capture platform. The transaction strengthened the use of movement-based AI for patient assessment, exercise scoring, progress tracking, and digital musculoskeletal care.
January 2025 – DIH partnered with Nobis Rehabilitation Partners
DIH entered a partnership with Nobis Rehabilitation Partners to deploy an overground gait and balance-training system across newly established rehabilitation hospitals. The agreement indicates movement from individual equipment sales toward standardized deployment across hospital networks.
February 2025 – DIH expanded its Gulf distribution network
DIH extended its partnership with Zahrawi Group into Saudi Arabia. The arrangement expanded the companies’ combined coverage across Saudi Arabia, the UAE, Qatar, and Bahrain. Local distribution will improve access to installation, training, maintenance, and technical support.
January 2026 – China promoted technology-enabled elderly rehabilitation
Chinese authorities issued guidelines encouraging the use of exoskeleton robots, muscle-support systems, brain-computer interfaces, and related technologies for elderly citizens with declining physical function. This could accelerate domestic development and institutional adoption of rehabilitation equipment.
Opportunities and Business Insights
Emerging Hospital Infrastructure
China, India, Saudi Arabia, Southeast Asia, and selected Latin American markets are expanding hospitals and rehabilitation capacity. Suppliers offering scalable equipment packages can enter with basic systems and later add digital measurement, robotics, and software.
AI-Enabled Measurement
The strongest AI opportunity lies in movement analysis, exercise quality assessment, automatic repetition counting, adaptive resistance, and clinical documentation. Hospitals are more likely to adopt AI that saves therapist time than AI positioned as a replacement for clinical judgement.
Modular and Service-Based Procurement
Mid-priced modular systems can address the gap between conventional exercise machines and expensive robotics. Leasing, subscription models, managed maintenance, and pay-per-use structures may also reduce upfront procurement barriers.
The Hospital Exercise Equipment Market offers the clearest commercial opportunity to companies that combine durable equipment with training, data, maintenance, and measurable workflow benefits.
Principal Restraints
High Capital Cost: Robotic and sensor-based systems require larger budgets and longer approval cycles.
Uncertain Utilization: Advanced equipment may be underused when hospitals lack trained staff, suitable patients, or structured clinical protocols.
Regulatory and Data Requirements: Medical claims, connected software, AI functions, cybersecurity, and patient-data processing increase compliance costs.
Limited Reimbursement Linkage: Rehabilitation services may be reimbursed, but hospitals do not always receive separate payment for purchasing advanced equipment.
Service Dependence: Equipment downtime can reduce clinical capacity. Hospitals therefore avoid suppliers without reliable local maintenance and spare-parts support.
About Datavagyanik
Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advice to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals, and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis, and competitive intelligence.
Contact us:
Atul B (Sales Head)
Phone: +1 551 226 6002
Website: https://datavagyanik.com/
Email: sales@datavagyanik.com
